Kenvue (KVUE) Stock Forecast & Price Target

Q: What analysts cover Kenvue?

Kenvue has been rated by research analysts at Barclays , UBS Group , Weiss Ratings , and Zacks Research in the past 90 days.

$19.06 +0.27 (+1.41%)

As of 01:10 PM Eastern

Compare

Kenvue - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 15 Analyst Ratings

Sell
0

Hold
12

Buy
3

Based on 15 Wall Street analysts who have issued ratings for Kenvue in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 12 have given a hold rating, and 3 have given a buy rating for KVUE.

Consensus Price Target

$19.27
1.14% Upside

According to the 15 analysts' twelve-month price targets for Kenvue, the average price target is $19.27. The highest price target for KVUE is $22.00, while the lowest price target for KVUE is $18.00. The average price target represents a forecasted upside of 1.14% from the current price of $19.06.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for KVUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kenvue and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KVUE Analyst Ratings Over Time

Type	Current Forecast 8/18/25 to 8/18/26	1 Month Ago 7/19/25 to 7/19/26	3 Months Ago 5/20/25 to 5/20/26	1 Year Ago 8/18/24 to 8/18/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	5 Buy rating(s)
Hold	12 Hold rating(s)	13 Hold rating(s)	12 Hold rating(s)	7 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$19.27	$19.50	$19.33	$24.38
Forecasted Upside	1.14% Upside	2.95% Upside	11.58% Upside	15.41% Upside
Consensus Rating	Hold	Hold	Hold	Hold

KVUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

KVUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Kenvue Stock vs. The Competition

Type	Kenvue	Consumer Staples Companies	Broader Market
Consensus Rating Score	2.20	2.24	2.53
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	2.35% Upside	138.99% Upside	12.16% Upside
News Sentiment Rating	Positive News See Recent KVUE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
8/11/2026	UBS Group 4 of 5 stars	Peter Grom 3 of 5 stars	Lower Target	Neutral	$20.00 ➝ $19.00	+0.18%
7/21/2026	Barclays 3 of 5 stars	Lauren Lieberman 2 of 5 stars	Boost Target	Equal Weight	$18.00 ➝ $19.00	+0.03%
7/7/2026	Zacks Research 5 of 5 stars		Downgrade	Strong-Buy ➝ Hold
6/15/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C-) ➝ Hold (C)
4/15/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$20.00 ➝ $19.00	+9.79%
3/6/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold
2/18/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$17.00 ➝ $18.00	-3.92%
1/30/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Devas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$23.00 ➝ $18.00	+4.74%
11/3/2025	Edward Jones Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
10/28/2025	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Javier Escalante Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$18.00	+24.27%
Iran War: What Happened at 1:11 P.M. Outside D.C.? (Ad) A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 trillion dollar financial story unfolding behind the Iran conflict. Addison Wiggin, founder of the Grey Swan Investment Fraternity, investigated the claims himself and found enough corroboration to bring the story forward. The full account follows the money behind the headlines and shows why the Iran situation may look very different than reported. See the full investigation into the Iran money trail now
10/28/2025	Johnson Rice Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral
10/24/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$18.00	+19.32%
10/10/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$24.00 ➝ $21.00	+24.15%
10/8/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Lizzul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$25.00 ➝ $21.00	+30.39%
10/2/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bonnie Herzog Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$22.00 ➝ $19.00	+20.52%
9/26/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$22.00	+35.79%
8/8/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Perform	$24.00 ➝ $22.00	+3.17%
2/24/2025	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Korinne Wolfmeyer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$24.00 ➝ $27.00	+15.85%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:10 PM ET.

Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, August 12, 2026. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

Kenvue
Bull Case

Here are some ways that investors could benefit from investing in Kenvue Inc.:

The company reported earnings per share (EPS) of $0.32 for the latest quarter, exceeding analysts' expectations, which indicates strong financial performance and potential for growth.
Kenvue Inc. achieved a revenue of $3.91 billion during the quarter, surpassing forecasts, suggesting robust demand for its consumer health products.
With a return on equity of 20.81%, Kenvue Inc. demonstrates effective management and profitability, which can attract investors looking for solid returns.
The current stock price is around $17.66, which may be considered attractive for investors looking for entry points in a growing consumer health market.
The company has a history of increasing revenue, with a 4.5% rise compared to the same quarter last year, indicating a positive growth trajectory.

Kenvue
Bear Case

Investors should be bearish about investing in Kenvue Inc. for these reasons:

The payout ratio is currently at 97.65%, which is quite high and may raise concerns about the sustainability of dividend payments in the future.
Insider ownership is relatively low at 1.59%, which might indicate a lack of confidence from those who know the company best.
Despite recent revenue growth, the competitive landscape in the consumer health sector is intense, which could impact future profitability.
Recent insider selling, including a significant transaction by the General Counsel, may signal potential concerns about the company's future performance.
Institutional investors hold a substantial 97.64% of the stock, which could lead to volatility if large shareholders decide to sell their positions.

KVUE Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Kenvue is $19.27, with a high forecast of $22.00 and a low forecast of $18.00.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last year. There are currently 12 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.

According to analysts, Kenvue's stock has a predicted upside of 1.14% based on their 12-month stock forecasts.

Over the previous 90 days, Kenvue's stock had 2 downgrades and 1 upgrade by analysts.

Kenvue has been rated by research analysts at Barclays, UBS Group, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Kenvue less than other "consumer staples" companies. The consensus rating score for Kenvue is 2.20 while the average consensus rating score for "consumer staples" companies is 2.24. Learn more on how KVUE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Kenvue Recommendations

This page (NYSE:KVUE) was last updated on 8/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kenvue (KVUE) Stock Forecast & Price Target